<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN" "JATS-archivearticle1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JPSIM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Pakistan Society of Internal Medicine</journal-title>
        <abbrev-title>J Pak Soc Intern Med</abbrev-title>
      </journal-title-group>
      <issn publication-format="print">2709-8729</issn>
      <issn publication-format="electronic">2710-0804</issn>
      <publisher>
        <publisher-name>Pakistan Society of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.70302/jpsim.v7i4.2667</article-id>
      <article-id pub-id-type="publisher-id">jpsim.v7i4.2667</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Lactate Dehydrogenase to Albumin Ratio As Prognostic Biomarker in Sepsis: A Retrospective Study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Suhail</surname>
            <given-names>Amna</given-names>
          </name>
          <email>amna.akhter06@gmail.com</email>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bangash</surname>
            <given-names>Anam Fatima</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suhail</surname>
            <given-names>Muzna</given-names>
          </name>
          <xref ref-type="aff" rid="aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tahir</surname>
            <given-names>Iqra</given-names>
          </name>
          <xref ref-type="aff" rid="aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Butt</surname>
            <given-names>Nasir Farooq</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <institution>Lahore General Hospital</institution>
        <country>Pakistan</country>
      </aff>
      <aff id="aff2">
        <institution>Mayo Hospital Lahore</institution>
        <country>Pakistan</country>
      </aff>
      <aff id="aff3">
        <institution>University of Lahore</institution>
        <country>Pakistan</country>
      </aff>
      <aff id="aff4">
        <institution>Tehsil Headquarter Sharaqpur</institution>
        <country>Pakistan</country>
      </aff>
      <author-notes>
        <corresp id="cor1">*Correspondence: Amna Suhail (amna.akhter06@gmail.com)</corresp>
        <fn fn-type="conflict">
          <p>The authors declare no conflict of interest.</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-11-20">
        <day>20</day>
        <month>11</month>
        <year>2026</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2026</year>
      </pub-date>
      <volume>7</volume>
      <issue>4</issue>
      <fpage>337</fpage>
      <lpage>344</lpage>
      <history>
        <date date-type="received" iso-8601-date="2026-10-20">
          <day>20</day>
          <month>10</month>
          <year>2026</year>
        </date>
        <date date-type="accepted" iso-8601-date="2026-11-20">
          <day>20</day>
          <month>11</month>
          <year>2026</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2026 The Author(s)</copyright-statement>
        <copyright-year>2026</copyright-year>
        <copyright-holder>The Author(s)</copyright-holder>
        <ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v7i4.2667" content-type="text/html"/>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v7i4.2667.pdf" content-type="application/pdf"/>
      <abstract>
        <sec>
          <title>Objective</title>
          <p>To evaluate the prognostic value of the lactate dehydrogenase to albumin ratio in predicting the outcomes of patients admitted with sepsis.</p>
        </sec>
        <sec>
          <title>Methodology</title>
          <p>This retrospective cohort study was conducted in the medical units of Mayo Hospital. Records of 168 patients admitted with sepsis from March 2022 to March 2023 were obtained after permission from the ethical review board. Lactate dehydrogenase to albumin ratio was calculated from the investigations done at the time of admission. Outcome of patients was noted. Multivariable regression and receiver operating characteristics curve analysis was carried out to determine usefulness of this ratio. Categorical variables were expressed in percentages and continuous variables by median (interquartile range).</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Out of 168 patients 104 (61.9%) were males and 64 (38.1%) were females with a mean age of 55 years [interquartile range=38-66 years]. One hundred and seven patients (63.6%) were discharged and the remaining expired. All-cause mortality was higher in patients with high lactate dehydrogenase to albumin ratio (p value</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Lactate dehydrogenase to albumin ratio can be used as a predictive biomarker of mortality in patients admitted with sepsis.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en" kwd-group-type="author-keywords">
        <title>Keywords</title>
        <kwd>Lactate dehydrogenase</kwd>
        <kwd>serum albumin</kwd>
        <kwd>sepsis</kwd>
        <kwd>infection</kwd>
      </kwd-group>
      <funding-group>
        <funding-statement>This research received no specific grant from any funding agency.</funding-statement>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>One of the major challenges faced by the emergency department physicians, is the management of patients with sepsis1. Sepsis is a life-threatening condition that occurs as the result of the body's immunological response to an infectious agent and despite significant advancements, it remains a major cause of morbidity and mortality2, 3. It has also been recognized as a global health priority by the World Health Organization and has been redefined in the 2023 guidelines as “<italic>life threatening organ dysfunction resulting from a dysregulated host response to infection”, </italic>thus focusing more on the deadliness and acute severity of this medical condition4.</p>
      <p>In an analysis by Global Burden of Diseases Injuries and Risk Factor studies, 48.9 million cases of sepsis and 11 million sepsis related deaths were recorded worldwide. In developing countries, sepsis remains a major cause of intensive care unit (ICU) admission with mortality of, as high as 80%5.</p>
      <p>The characteristic feature of sepsis is systemic inflammation with clinical symptoms including hypotension, tachycardia, hyperventilation, leukocytosis and leukopenia, with hypothermia or fever4. With sepsis being a time-dependent disease, requires the emergency physician to implement an intensive and efficacious disease management, which is facilitated by early recognition of the condition and assessing the risk by identifying the prognostic markers1. Various scores and independent mortality predictors have been devised, some of them include increased age, tachycardia, elevated C-reactive proteins and lactate and need of mechanical ventilation. Similarly, scores used to predict mortality include Systemic Inflammatory Response Syndrome (SIRS), National Early Warning Score (NEWS), Acute Physiology and Chronic Health Evaluation (APACHE II), Sequential Organ Failure Assessment (SOFA) and Quick Sequential Organ Failure Assessment Score (qSOFA)6,7.</p>
      <p>In the field of sepsis multitude of biomarkers have been proposed, indicating their significance in predicting the absence, presence or severity of sepsis8. Physicians all around the globe are in a continuous search of new markers and some of the newly identified severity markers and mortality predictors which are still under study, including pro- BNP, interleukin-6, international normalized ratio etc9. In 2010 and 2020, Pierrakos et al. conducted literature review, indicating that over 100 biomarkers have been studied up until now, out of which C-reactive protein (CRP) and procalcitonin (PCT) only made it to clinical practice8,10.</p>
      <p>Lactate dehydrogenase (LDH) and albumin levels are affected in infection, thus having the potential of being used as a biomarker of mortality. However, their levels are influenced by various other factors as well including liver disease, malabsorption etc.11-13. LDH may serve as a prognostic factor for sepsis as its level increases, in accordance with the severity of the infection and serum albumin level decreases with higher mortality14,15. In addition, nutritional status and chronic inflammatory conditions affects albumin level as well. Therefore, based on these limitations, the better prognostic marker associated with multi organ failure and mortality in sepsis is believed to be lactate/albumin ratio16, or use of other composite ratios like blood urea nitrogen to albumin (BUN/ALB) ratio, C-reactive protein to albumin (CRP/ALB) ratio, and procalcitonin to albumin ratio has been suggested in other studies as well3.</p>
      <p>Further research is warranted to establish these composite ratios as indicators of survival in septic patients. In this study, we propose to explore one such composite ratio, LDH/ albumin ratio as a prognostic indicator in sepsis. It can help us in identification and intensification of treatment of high-risk patients especially in countries with limited resources and high disease burden. To the best of our knowledge, no study in Pakistan has evaluated the prognostic value of LDH/Albumin ratio in septic patients in the emergency department of either governmental or private hospitals.</p>
    </sec>
    <sec>
      <title>Methodology</title>
      <p>This retrospective cohort study was conducted to determine the serum lactate dehydrogenase to albumin ratio as prognostic factor among patients admitted with sepsis in the medical wards of Mayo hospital. This study was approved from the Institutional Review with reference number 791/RC/KEMU. The consent of study population was waived off by the ethical review board.</p>
      <p>The study was conducted in one of the largest tertiary care hospitals in Lahore. Data was obtained from the hospital records of the sepsis patients admitted in the in-patient medical units between March 2022 and March 2023, following their discharge or death. Patient’s data was extracted from the existing medical records, including demographic details, clinical characteristics, lab findings and outcomes. There was however, no real time data collection or patients observation made by the investigators.</p>
      <p>A total of 168 eligible sepsis patient’s hospital records were included in the study, by convenience-based sampling. Patients with sepsis were identified using Systemic Inflammatory Response Syndrome criteria characterized by increased heart rate (more than 90 beats/min), increased respiratory rate (more than 20 breaths/min), fever or hypothermia (temperature &gt;38 °C or &lt;36 °C), and leucocytosis, leukopenia, or bandemia (white blood cells &gt;1,200/mm³, &lt;4,000/mm³ or bandemia ≥10%)17</p>
      <p><italic>Inclusion Criteria</italic><italic> &amp; Exclusion Criteria:</italic> Patients aged 18 years or more, who met two or more of the above-mentioned criteria and had a suspected source of infection based on history and examination available in medical records were included in the study. Pregnant patients, patients with malignancy, malabsorption syndrome were excluded so were the patients with hospital stay of less than 8 hours and those who denied resuscitation.</p>
      <p>The main predictive variables used in this study include the serum lactate dehydrogenase to albumin ratio, which was calculated from the individual values recorded in the files at the admission of the patients. After calculations, we documented the LDH/Albumin ratio on a predesigned Performa. Outcome variable measured for this study include hospital discharge or in-hospital mortality of the patients.</p>
      <p>Data was collected from the already available hospital records of patients with sepsis who were admitted in medical wards between March 2022 to March 2023 following their discharge or death. Demographic information like name, age and gender, outcome of patients, pre-existing comorbidities, vital signs, oxygen saturation at presentation, serum lactate dehydrogenase (noted in International units/ liter), serum albumin (noted in grams/deciliter) and other baseline laboratory data were obtained from the files which were in accordance to the investigations done at the time of admission. Serum lactate dehydrogenase to albumin ratio was calculated and recorded on predesigned proforma by the hospital.</p>
      <p><italic>Sample Size</italic><italic>:</italic> One hundred and sixty four patient’s data was included. The sample size was statistically calculated where. P is the prevalence rate. Level of significance is 7% and d is the margin of error. Using prevalence rate as 30%.</p>
      <p><italic>Statistical Analysis</italic><italic>:</italic> Data was analyzed using IBM SPSS Statistics (Version 22) and under suitable requests to the authors, can be made available. Univariate analysis followed by multivariate logistic regression analysis was carried out to identify significant mortality indicators (p value &lt; 0.05). Chi squared tests were utilized for analysis of categorical variables, while <bold>S</bold>tudent’s t tests and descriptive frequencies for continuous variables. Categorical variables were expressed in percentages and continuous variables by median (interquartile range). Serum albumin, lactate dehydrogenase and lactate dehydrogenase to albumin ratio, all were significant in-patient mortality predictors in our study population. Receiver operator characteristic curve was constructed for these three variables. A suitable cut off using Youden index for lactate dehydrogenase to albumin ratio was obtained from the curve. Sensitivity and specificity for this cut off value as mortality predictor was also derived from the graph.</p>
    </sec>
    <sec>
      <title>Results</title>
      <p>Out of 168 patients admitted, 107 (63.7%) were discharged and remaining patients did not survive. In the data under study, majority of the patients were males (61.9%), with mean age of the subjects 55 years [interquartile range = 38-66 years]. Lower respiratory tract infection was the commonest cause of admission (45.2%) followed by urinary tract infection (23.8%), with least number of in-hospital mortalities documented in patients with intra-abdominal infection (3.3%) (Table 1.). Furthermore, majority of the patients admitted were suffering from hypertension (51.8%), diabetes (29.8%) and chronic kidney diseases (20.2%). Table 1 shows the univariate regression analysis of various demographic characteristics and variables, implying significance of LDH to albumin ratio as predictive indicator (<italic>p &lt; 0.001</italic>).</p>
      <table-wrap id="tbl1">
        <label>Table 1</label>
        <table>
          <tbody>
            <tr>
              <td>Table. 1. Comparison of baseline characteristics between Discharged and Expired patients.</td>
            </tr>
            <tr>
              <td>Characteristics</td>
              <td>Overall (n=168)</td>
              <td>Discharged(n=107)</td>
              <td>Expired (n=61)</td>
              <td>p-value</td>
            </tr>
            <tr>
              <td>Age</td>
              <td>55 (38 - 66)</td>
              <td>48 (35 – 65)</td>
              <td>60 (55 – 70)</td>
              <td></td>
            </tr>
            <tr>
              <td>Sex
 Male
 Female</td>
              <td>104 (61.9%)
64 (38.1%)</td>
              <td>70 (65.4%)
37 (34.6%)</td>
              <td>34 (55.7%)
27 (44.3%)</td>
              <td>0.214</td>
            </tr>
            <tr>
              <td>Comorbidities
 Hypertension
 Diabetes
 Chronic Kidney Disease
 Chronic Liver Disease
 Cerebrovascular accident
 Hyperthyroidism
 Hypothyroidism
 Ischemic Heart Disease
 Tuberculosis
 Asthma 
 COPD
 ILD
 BPH
 IV Drug Abuser
 Hepatitis C</td>
              <td>87 (51.8%)
50 (29.8%)
34 (20.2%)
4 (2.4%)
12 (7.1%)
1 (0.6%)
1 (0.6%)
21 (12.5%)
2 (1.2%)
6 (3.6%)
16 (9.5%)
1 (0.6%)
1 (0.6%)
1 (0.6%)
8 (4.8%)</td>
              <td>58 (54.2%)
25 (23.4%)
16 (15%)
1 (0.9%)
0 (0%)
1 (0.9%)
0 (0%)
7 (6.5%)
0 (0%)
4 (3.7%)
13 (12.1%)
0 (0%)
1 (0.9%)
1 (0.9%)
5 (4.7%)</td>
              <td>29 (47.5%)
25 (41.0%)
18 (29.5%)
3 (4.9%)
5 (8.2%)
0 (0.0%)
1 (1.6%)
14 (23%)
2 (3.3%)
2 (3.3%)
3 (4.9%)
1 (1.6%)
0 (0.0%)
1 (1.6%)
3 (4.9%)</td>
              <td>0.406
0.016*
0.024*
0.103
0.689
0.449
0.184
0.002*
0.060
0.877
0.125
0.184
0.449
0.453
0.943</td>
            </tr>
            <tr>
              <td>Suspected Infection Source
 Respiratory tract infection
 Urinary tract infection
 Intra-abdominal infection
 CNS infection
 Other</td>
              <td>76 (45.2%)
40 (23.8%)
23 (13.7%)
11 (6.5%)
18 (10.7%)</td>
              <td>45 (42.1%)
24 (22.4%)
21 (19.6%)
8 (7.5%)
9 (8.4%)</td>
              <td>31 (50.8%)
16 (26.2%)
2 (3.3%)
3 (4.9%)
9 (14.8%)</td>
              <td>0.272
0.578
0.003*
0.519
0.201</td>
            </tr>
            <tr>
              <td>Vital Signs
 SBP (mmHg)
 DBP (mmHg)
 Heart rate (per min)
 Body Temp. °F</td>
              <td>100 [90 – 130]
70 [60 – 80]
109 [99 – 114]
100.50 [100 – 101]</td>
              <td>100 [90 – 120] 
70 [60 – 80]
106 [98 – 112]
100 [100 – 101]</td>
              <td>100 [90 – 130]
70 [ 60 – 90]
112 [107 – 118]
101 [100 – 102]</td>
              <td>0.309
0.192
0.152
&lt; 0.001*</td>
            </tr>
            <tr>
              <td>SpO2 (%)</td>
              <td>95 [92 – 97]</td>
              <td>96 [93- 97]</td>
              <td>92 [91 – 96]</td>
              <td>&lt; 0.001*</td>
            </tr>
            <tr>
              <td>Laboratory data
WBC, /mm3
Hb, g/dl
Platelets 
ALB, g/dl
Urea, 
LDH</td>
              <td>16 [13.90 – 19.68]
11.20 [9.20 – 12.98]
225.50 [148.25 – 281.75]
2.9 [2.4 – 3.3]
62.50 [46 – 100]
515.5 [374.75 – 728]</td>
              <td>15.6 [13.7 – 18.8]
12 [9.8 – 13]
234 [178 – 320]
3.1 [2.6 – 3.5]
57 [45 – 78]
455 [347 – 666]</td>
              <td>17.10 [14.45-23.10]
9.80 [8.85 – 11.85]
178 [108.5 – 246]
2.7 [2.3 – 3.1]
72 [53.5 – 118.5]
605 [453.5 – 813.5]</td>
              <td>0.040*
0.006*
0.040*
0.001*
0.055</td>
            </tr>
            <tr>
              <td>LDH/ALB ratio</td>
              <td>190.03 [128.86-264.64]</td>
              <td>158.28 [106.06- 226.80]</td>
              <td>241.7 [182.59–340.2]</td>
              <td>&lt; 0.001*</td>
            </tr>
            <tr>
              <td>Categorical variables are expressed by number (%), and continuous variables are expressed by median [interquartile range]. 
COPD = Chronic Obstructive pulmonary disease, ILD = Interstitial lung disease, BPH = Benign Prostatic hyperplasia SBP = Systolic Blood Pressure, DBP = Diastolic Blood Pressure, WBC = White Blood Cells, Hb = Hemoglobin, ALB = Albumin, LDH = Lactate dehydrogenase, Sp02 = Oxygen Saturation measured by pulse oximeter.</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Significant prognostic factors for the in-hospital mortality were further analyzed in table 2. by using multivariate regression analysis. With increase in age the probability of in-hospital mortality significantly increases (<italic>p &lt; 0.001</italic>), also ischemic heart disease was found to be a significant risk factors for mortality (<italic>p =</italic> <italic>0.002</italic>), as compared to other comorbidities. Furthermore, increase in body temperature and decrease in saturation also marked as increased evidence of expiry among the patients. The probability of LDH/ALB ratio, to be an independent predictor of in-hospital mortality was significantly supported within the results with odd ratio of 1.006 (95% confidence interval [CI]: 1.003 –1.010, <italic>p &lt; 0.001</italic>).</p>
      <table-wrap id="tbl2">
        <label>Table 2</label>
        <caption>
          <title>Multivariate logistic regression analysis of the prognostic factors for the in-hospital mortality</title>
        </caption>
        <table>
          <tbody>
            <tr>
              <td>Variables</td>
              <td>β –value</td>
              <td>Odd Ratio (OR) (95% Confidence interval)</td>
              <td>p-value</td>
            </tr>
            <tr>
              <td>Age</td>
              <td>0.037</td>
              <td>1.038 (1.017 – 1.059)</td>
              <td>&lt; 0.001*</td>
            </tr>
            <tr>
              <td>Male</td>
              <td>- 0.407</td>
              <td>0.666 (0.350 – 1.267)</td>
              <td>0.215</td>
            </tr>
            <tr>
              <td>Comorbidities
Hypertension
Diabetes mellitus
Chronic kidney disease
Chronic liver disease Cerebrovascular accident
Ischemic Heart Disease
Asthma 
COPD
Hepatitis C</td>
              <td>-0.267
0.823
0.867
1.702
0.243
1.448
-0.136
-0.983
0.054</td>
              <td>0.766 (0.408 – 1.438)
2.278 (1.155 – 4.491)
2.381 (1.108 – 5.116)
5.483 (0.558 – 53.91)
1.276 (0.387 – 4.207)
4.225 (1.611 – 11.239)
0.873 (0.155 – 4.910)
0.374 (0.102 – 1.369)
1.055 (0.243 – 4.576)</td>
              <td>0.406
0.017*
0.026
0.111
0.691
0.002*
0.877
0.108
0.943</td>
            </tr>
            <tr>
              <td>Suspected Infection Source
Respiratory tract infection
Urinary tract infection
Intra-abdominal infection
CNS infection
Other</td>
              <td>0.353
0.207
-1.975
-0.446
0.634</td>
              <td>1.424 (0.757 – 2.678)
1.230 (0.593 – 2.550)
0.139 (0.031 – 0.615)
0.640 (0.163 – 2.509)
1.885 (0.705 – 5.038)</td>
              <td>0.273
0.580
0.001*
0.511
0.209</td>
            </tr>
            <tr>
              <td>Initial Vital Signs
Systolic BP (mmHg)
Diastolic BP (mmHg)
Body Temperature °F
Pulse</td>
              <td>0.006
0.014
0.169
0.062</td>
              <td>1.006 (0.995 – 1.016)
1.015 (0.993 – 1.037)
1.184 (0.939 – 1.492)
1.064 (1.026 – 1.102)</td>
              <td>0.309
0.192
0.149
&lt; 0.001*</td>
            </tr>
            <tr>
              <td>Sp02</td>
              <td>-0.210</td>
              <td>0.810 (0.732 – 0.897)</td>
              <td>&lt; 0.001*</td>
            </tr>
            <tr>
              <td>Laboratory data
White blood cell, /mm3
Hemoglobin, g/dl
Platelets 
*ALB, g/dl
Urea
LDH</td>
              <td>0.044
-0.177
-0.003
-0.895
0.005
0.002</td>
              <td>1.045 (1.000 – 1.091)
0.838 (0.736 – 0.954)
0.997 (0.995 – 1.000)
0.409 (0.241 – 0.693)
1.005 (1.000 – 1.011)
1.002 (1.001 – 1.004)</td>
              <td>0.041
0.006*
0.033
&lt; 0.001*
0.058
&lt; 0.001*</td>
            </tr>
            <tr>
              <td>LDH/ALB ratio</td>
              <td>0.006</td>
              <td>1.006 (1.003 – 1.010)</td>
              <td>&lt; 0.001*</td>
            </tr>
            <tr>
              <td>* ALB = Albumin, COPD= Chronic obstructive pulmonary disease, LDH= Lactate dehydrogenase, Sp02 = Oxygen Saturation measured by pulse oximeter</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Receiver operator curve constructed for the LDH/albumin ratio depicted an area of 0.735 (95% CI =0.659-0.810) under the curve as shown in Fig 1. It also establishes greatest sensitivity as mortality predictor of this composite ratio as compared to either LDH or albumin alone, as LDH/ALB ratio curve was higher as compared to other variables. Cut- off point for LDH/albumin ratio using Youden index was found to be 191.2 with a sensitivity of 70.5% and specificity of 37.4%.</p>
      <p><bold>Figure</bold> <bold>1</bold><bold>: ROC Curve comparing LAR (LDH/Albumin)</bold><bold> (AUC:</bold> <bold>0.735) </bold><bold>with LDH (Lactate Dehydrogenase)</bold><bold> (AUC:0.698)</bold><bold> and Albumin</bold><bold> (AUC: 0.334)</bold><bold> as prognostic factors. LAR (blue) shows highest sensitivity and specificity</bold><bold> (sensitivity 70.5%, specificity 37.4%)</bold><bold> as </bold><bold>compare</bold><bold> to LDH (green)</bold><bold> (sensitivity 62.3%, specificity 34.6%)</bold><bold> and Albumin (yellow)</bold><bold> (sensitivity 55.7%, specificity 77.6%)</bold><bold>. The reference line is represented as purple (no predictive value), indicating random guessing. </bold></p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>This study was aimed at evaluating the influence of prognostic factors i.e. LDH/Albumin ratio in predicting the mortality among septic patients. As, sepsis remains a challenge with overwhelming worldwide burden. Accurate and timely identification of high-risk patients is of paramount importance in treatment of these patients. By pinpointing high-risk patients, we can escalate our treatment strategies and administer appropriate broad-spectrum antimicrobial agents in a timely fashion. LDH levels are increased in compromised tissue perfusion and albumin is a negative acute phase reactant19. Our study confirms the utility of composite ratio of LDH to albumin as a prognostic indicator, promising better sensitivity as compared to LDH or albumin used individually. Hence, we suggest using this marker as a prognostic indicator in patients admitted with sepsis and planning their management accordingly. Other prognostic indicators of significance as per our data like age, presence of diabetes, chronic kidney disease etc. can also be used to construct a new mortality predictor score or to modify the already existing mortality scores for patients admitted with sepsis.</p>
      <p>In the present study, we found that age was a significant contributor in predicting mortality, as the patients who were of 60 years and older had a higher expiry rate than their younger counterparts did. This is in accordance with a study conducted in the USA, where they evaluated the influence of age on negative outcomes in patients with sepsis. They corresponded age with poorer outcomes, indicating that 20-32% increased odds of mortality occurs with an increase of each decade of life20. With age, the other significant prognostic indicator reported in our study was chronic diseases, with an increased report of deaths in patients who were already suffering from diabetes mellitus, chronic kidney disease and Ischemic Heart Disease. Previous studies have reported the influence of chronic disease as a prognostic indicator, with one study indicating increased odds of mortality in patients with end stage renal disease21. While conversely another study from China, on critically ill patients with sepsis, did not find an increased in mortality in patients with comorbid diabetes mellitus22. Source of infection also predicted the outcome of patients in our study, with a higher evidence of hospital discharge observed in patients with intra-abdominal source of infection. Previous studies have reported the source of infection to be an independent predictor of mortality. With one study indicating reporting that, patients with pneumonia as a primary source showed higher mortality rate, while patients with sepsis originating from a urinary tract infection showed less23. Other significant prognostic indicators observed were high fever, reduced oxygen saturation and variation the clinical laboratory values of white blood cells, platelets and hemoglobin. Previously, separate works have been done in evaluating the independent prognostic values of the above-mentioned variables in patients with sepsis; some have reported results similar to ours while others have documented contradictory outcomes24. However, further study is required to evaluate the influence of these predictors on survival of the patients with sepsis.</p>
      <p>There are several other similar studies, which support our findings. A study conducted by Young SJ et al. in the Republic of Korea revealed that LDH/ albumin ratio predicted mortality with a sensitivity of 81.5% and a specificity of 41.2% in patients admitted to intensive care units with sepsis. Majority of the patients in their study, like that of ours, were admitted with respiratory tract infection. They concluded that APACHE II and MEDS could be improved by adding LDH/ Albumin ratio in it (p value &lt; 0.001). They further investigated other albumin-based ratios like C-reactive protein, lactate and blood urea nitrogen to albumin ratios. Interestingly, LDH/albumin ratio had the greatest area under the curve and was the most sensitive mortality predictor amongst all these novel biomarkers of mortality prediction3. These findings are very close to that of ours. Young SJ et al. included patients admitted in intensive care units only while our study was inclusive of all the patients with sepsis on the medical floor. Taking it one step ahead, research by Xu Z et al. on 4,666 patients, exhibited the same results while approving application of this novel ratio.</p>
      <p>It is worthwhile to note that we were not able to find any study contradicting to our findings related to LDH/Albumin ratio as mortality predictor, thus further implying its strength as a reliable, and significant marker of mortality. Additionally, we also propose to design studies, in which we can relate progression of disease and patients’ response to treatment during admission with LDH/albumin ratio. Limitations observed in our study, include small sample size and the fact that it is a single centered study thus having innate shortcoming related to selection bias. More multi-centered, prospective studies with larger populations are warranted to establish generalizability of the sensitivity and specificity of LDH/albumin ratio as mortality predictor. Furthermore, we were not able to compare LDH/ albumin ratio to other traditionally used markers and scores like CRP, serum lactate, SOFA score etc. as some of these labs are not routinely available in the hospital. Similarly, we had to rely on SIRS criteria for patient selection, as all the parameters for the SOFA criteria were not available in patient’s records.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>In conclusion, this present retrospective cohort study demonstrated an increased LDH/albumin ratio to be a dependable biomarker of mortality predictor in patients admitted with sepsis. Although other significant predictor variables were also identified in this study, which warrant further analysis on a large</p>
    </sec>
    <sec>
      <title>Authors’ Contribution</title>
      <p>AS: Conception.</p>
      <p>AFB, MS: Design of the work.</p>
      <p>IT, NFB: Data acquisition, analysis, or interpretation.</p>
      <p>AFB, MS, IT: Draft the work.</p>
      <p>AS, NFB: Review critically for important intellectual content.</p>
      <p>All authors approve the version to be published.</p>
      <p>All authors agree to be accountable for all aspects of the work.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>We would like to acknowledge Prof. Dr. Adil Iqbal and Dr. Rabia Rathore for their critical appraisal of the research proposal and their guidance and support at each step of the publication</p>
      <p>Ethical Approval: The IRB/EC approved this study via letter no. 791/RC/KEMU dated September 27, 2022.</p>
      <p>Conflict of Interest:    None</p>
      <p>Funding Source:    None</p>
    </ack>
    <notes notes-type="author-contributions">
      <title>Author Contributions</title>
      <p>AS: Conception.</p>
      <p>AFB, MS: Design of the work.</p>
      <p>IT, NFB: Data acquisition, analysis, or interpretation.</p>
      <p>AFB, MS, IT: Draft the work.</p>
      <p>AS, NFB: Review critically for important intellectual content.</p>
      <p>All authors approve the version to be published.</p>
      <p>All authors agree to be accountable for all aspects of the work.</p>
    </notes>
    <notes notes-type="ethics-statement">
      <title>Ethics Statement</title>
      <p>Ethics committee: King Edward Medical University. Approval number: 791/RC/KEMU.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation>Gavelli F, Castello LM, Avanzi GC. Management of sepsis and septic shock in the emergency department. Intern Emerg Med. 2021;16(6):1649–61.</mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation>Gyawali B, Ramakrishna K, Dhamoon AS. Sepsis: The evolution in definition, pathophysiology, and management. SAGE Open Med. 2019; <pub-id pub-id-type="doi">10.1177/2050312119835043</pub-id></mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation>Jeon SY, Ryu S, Oh SK, Park JS, You YH, Jeong WJ, et al. Lactate dehydrogenase to albumin ratio as a prognostic factor for patients with severe infection requiring intensive care. Medicine (Baltimore). 2021;100(6):e27538.</mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation>Santacroce E, D’Angerio M, Ciobanu AL, Masini L, Lo Tartaro D, Coloretti I, et al. Advances and challenges in sepsis management: Modern tools and future directions. Cells. 2024;13(2):439.</mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation>Pant A, Mackraj I, Govender T. Advances in sepsis diagnosis and management: A paradigm shift towards nanotechnology. J Biomed Sci. 2021;28(1):60.</mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation>Mohamed AKS, Mehta AA, James P. Predictors of mortality of severe sepsis among adult patients in the medical intensive care unit. Lung India. 2017;34(4):330–5.</mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation>Ramdeen S, Ferrell B, Bonk C, Schubel L, Littlejohn R, Capan M, et al. The available criteria for different sepsis scoring systems in the emergency. Open Access Emerg Med. 2021;<pub-id pub-id-type="doi">10.2147/OAEM.S280279</pub-id></mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation>Pierrakos C, Vincent J-L. Sepsis biomarkers: A review. Crit Care. 2010;14(1):R15.</mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <mixed-citation>Liu J, Bai C, Li B, Shan A, Shi F, Yao C, et al. Mortality prediction using a novel combination of biomarkers in the first day of sepsis in intensive care units. Sci Rep. 2021;<pub-id pub-id-type="doi">10.1038/s41598-020-79843-5</pub-id></mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <mixed-citation>Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL. Biomarkers of sepsis: Time for a reappraisal. Crit Care. 2020;<pub-id pub-id-type="doi">10.1186/s13054-020-02993-5</pub-id></mixed-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <mixed-citation>Lu J, Wei Z, Jiang H, Cheng L, Chen Q, Chen M, et al. Lactate dehydrogenase is associated with 28-day mortality in patients with sepsis: A retrospective observational study. J Surg Res. 2018;<pub-id pub-id-type="doi">10.1016/j.jss.2018.03.035</pub-id></mixed-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <mixed-citation>Yin M, Si L, Qin W, Li C, Zhang J, Yang H, et al. Predictive value of serum albumin level for the prognosis of severe sepsis without exogenous human albumin administration: A prospective cohort study. J Intensive Care Med. 2018;33(10):687–94.</mixed-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <mixed-citation>Arnau-Barrés I, Güerri-Fernández R, Luque S, Sorli L, Vázquez O, Miralles R. Serum albumin is a strong predictor of sepsis outcome in elderly patients. Eur J Clin Microbiol Infect Dis. 2019;38(4):743–6.</mixed-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <mixed-citation>Wang J, Fei W, Song Q. One-year mortality prediction for patients with sepsis: A nomogram integrating lactic dehydrogenase and clinical characteristics. BMC Infect Dis. 2023;<pub-id pub-id-type="doi">10.1186/s12879-023-08636-8</pub-id></mixed-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <mixed-citation>Fang Y, Zhang Y, Zhang X. The elevated lactate dehydrogenase to albumin ratio is a risk factor for developing sepsis-associated acute kidney injury: A single-center retrospective study. BMC Nephrol. 2024;<pub-id pub-id-type="doi">10.1186/s12882-024-03636-5</pub-id></mixed-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <mixed-citation>Gharipour A, Razavi R, Gharipour M, Mukasa D. Lactate/albumin ratio: An early prognostic marker in critically ill patients. Am J Emerg Med. 2020;38(10):2088–95.10.</mixed-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <mixed-citation>Marik PE, Taeb AM. SIRS, qSOFA and new sepsis definition. J Thorac Dis. 2017;9(4):943–5.</mixed-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <mixed-citation>Rhee C, Jones TM, Hamad Y, Pande A, Varon J, O’Brien C, et al. Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals. JAMA Netw Open. 2019;2(2):e187571.</mixed-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <mixed-citation>Alizadeh N, Tabatabaei FS, Azimi A, Faraji N, Akbarpour S, Dianatkhah M, et al. Lactate dehydrogenase to albumin ratio as a predictive factor of covid-19 patients’ outcome; a cross-sectional study. Archives of Academic Emergency Medicine 2022; 10. <pub-id pub-id-type="doi">10.22037/aaem.v10i1.1646</pub-id></mixed-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <mixed-citation>Cerceo E, Rachoin JS, Gaughan J, Weisberg L. Association of gender, age, and race on renal outcomes and mortality in patients with severe sepsis and septic shock. J Crit Care. 2021;<pub-id pub-id-type="doi">10.1016/j.jcrc.2020.10.007</pub-id>.</mixed-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <mixed-citation>Bou Chebl R, Tamim H, Abou Dagher G, Sadat M, Ghamdi G, Itani A, et al. Sepsis in end-stage renal disease patients: Are they at an increased risk of mortality? Ann Med. 2021;53(1):1737-43.</mixed-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <mixed-citation>Lin S, Ge S, He W, Zeng M. Association between comorbid diabetes mellitus and prognosis of patients with sepsis in the intensive care unit: A retrospective cohort study. Ann Transl Med. 2021;9(22):1699.</mixed-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <mixed-citation>Peters-Sengers H, Butler JM, Uhel F, Schultz MJ, Bonten MJ, Cremer OL, et al. Source-specific host response and outcomes in critically ill patients with sepsis: A prospective cohort study. Intensive Care Med. 2022;48(1):92–102.</mixed-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <mixed-citation>Dias A, Gomez V, Viola L, Rodrigues A, Weber S, Tartaro L. Fever is associated with earlier antibiotic onset and reduced mortality in patients with sepsis admitted to the ICU. Sci Rep. 2021;<pub-id pub-id-type="doi">10.1038/s41598-021-03296-7</pub-id>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
